CRON Q3 2021 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$981M

Q3 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$20M+79.7% YoY

Gross Profit

-$730,000-3.6% margin

Operating Income

-$56M-276.4% margin

Net Income

$78M381.8% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

+30.6%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$34M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$100M

Stockholders' Equity

$1.8B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$11M	+79.7%
Gross Profit	-$730,000	-$2M	+52.5%
Operating Income	-$56M	-$41M	-37.0%
Net Income	$78M	$69M	+12.9%

Revenue Segments

Cannabis Flower

$15M75%

Cannabis Extracts

$5M24%

Product and Service, Other

$215,0001%

Geographic Segments

CANADA

$14M70%

ISRAEL

$4M18%

UNITED STATES

$2M10%

Other Countries

$369,0002%